|
NSUN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60259999995682E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.207700E-04 |
| Normal-vs-Stage2 |
3.482100E-02 |
| Normal-vs-Stage3 |
3.419400E-03 |
| Normal-vs-Stage4 |
2.028000E-02 |
| Stage1-vs-Stage2 |
4.928400E-01 |
| Stage1-vs-Stage3 |
1.119210E-01 |
| Stage1-vs-Stage4 |
2.849200E-01 |
| Stage2-vs-Stage3 |
4.185400E-01 |
| Stage2-vs-Stage4 |
7.071800E-01 |
| Stage3-vs-Stage4 |
7.303200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61750999999599E-05 |
| Normal-vs-AfricanAmerican |
5.837300E-03 |
| Normal-vs-Asian |
2.66660000003416E-06 |
| Caucasian-vs-AfricanAmerican |
2.088400E-01 |
| Caucasian-vs-Asian |
5.181900E-02 |
| AfricanAmerican-vs-Asian |
2.336400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68240000000464E-05 |
| Normal-vs-Female |
8.36370000000253E-05 |
| Male-vs-Female |
1.803830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.601900E-03 |
| Normal-vs-Extreme_Weight |
1.558690E-04 |
| Normal-vs-Obese |
2.477600E-03 |
| Normal-vs-Extreme_Obese |
1.902620E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.679800E-01 |
| Normal_Weight-vs-Obese |
8.677000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.179800E-02 |
| Extreme_Weight-vs-Obese |
8.070000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.200000E-02 |
| Obese-vs-Extreme_Obese |
9.865600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.586700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.35479999999288E-05 |
| Normal-vs-Age(61-80Yrs) |
3.630900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.810840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.241770E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.756500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.298430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.492400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.122000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.813200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.81924000000055E-05 |
| Normal-VS-Type2 PRCC |
1.574030E-02 |
| Normal-VS-KIRP CIMP |
5.111500E-02 |
| Normal-VS-Unclassified PRCC |
1.072250E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.135800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.741200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.546800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.566360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.236600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.153200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.861600E-03 |
| Normal-vs-N1 |
8.969400E-04 |
| Normal-vs-N2 |
8.575800E-01 |
| N0-vs-N1 |
4.329800E-02 |
| N0-vs-N2 |
8.210000E-01 |
| N1-vs-N2 |
2.629000E-01 |
|
|
